• What is Multiple Myeloma
  • The Use of Biosimilars in Hematology/Oncology Practice
  • Biosimilars for Hematologic Malignancies: Dissecting Real-World Evidence and Barriers to Utilization
  • Visit Our FAQ Library Now!
  • Practice Essentials in Multiple Myeloma
The Use of Biosimilars in Hematology/Oncology Practice

Dr. Charles Bennett, Dr. Marc Fishman, and Dr. Kevin Knopf




Developments in Newly Diagnosed Multiple Myeloma: Considerations for Improved Patient Outcomes

Coming Soon – On Demand Program
Earn CME/CPE/CNE Credit!
Sagar Lonial, MD, FACP